Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

superDimension is exhibiting at the American College of Chest Physicians (CHEST) annual meeting in San Diego at booth 819 and the American Society for Radiation Oncology ( ASTRO ) Conference in Chicago at booth 3216.

superDimension, Inc., a private company that develops minimally invasive interventional pulmonology devices, announced the launch of the iLogic System for early lung cancer detection and diagnosis.  The device is the second generation version of inReach, superDimension's electromagnetic navigation bronchoscopy (ENB) minimally invasive tool. The core technology for both inReach and iLogic extend beyond the capabilities of the traditional bronchoscope to distant, previously inaccessible regions of the lungs, and enables physicians to locate small lung lesions for diagnostic testing. superDimension debuted the iLogic system at the American College of Chest Physicians (CHEST) annual meeting in San Diego and the American Society for Radiation Oncology ( ASTRO ) Conference in Chicago. 

Improvements offered by the iLogic include a new software platform with a simplified positioning and navigational system that improves ease of use and further enhances visualization for the pulmonologist.  The virtual 3-D bronchial tree made possible with the technology extends deep into the lungs reaching more than 17 airway generations.   Further, the customized high-definition views available with iLogic offer physicians multiple navigation perspectives to improve detection and diagnosis.  A 26-inch high-definition wide screen format allows six viewports to be displayed simultaneously, including one video input, enabling the physician to evaluate positional data and optimize central and peripheral guidance within the lung.

Source: superDimension, Inc.